Literature DB >> 148520

Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation.

Y Uchida, N Yoshimoto, S Murao.   

Abstract

The effect of a new chemical agent, SG 75, on coronary blood flow of anesthetized dogs has been examined. Intravenous administrations of this agent in a dose of 10 microgram/Kg or over caused a significant increase in blood flow of non-constricted coronary artery. Percent increases in flow were 40 (10 microgram/Kg), 95 (50 microgram/Kg), 145 (100 microgram/Kg), and 195 (250 microgram/Kg). The increases were significantly larger than those caused by the same doses of diltiazem, verapamil, nitroglycerin, isosolbide dinitrate, and papaverine. The durations of the increase in flow were 12 (10 microgram/Kg), 23 (50 microgram/Kg), 28 (100 microgram/Kg), and 46 min (250 microgram/Kg), and they were longer than those caused by diltiazem and verapamil. A slight reduction in left ventricular tension and an increase in aortic blood flow were also observed following the administrations of SG 75 in a dose of over 50 microgram/Kg. A decrease in heart rate was produced with a dose of over 500 microgram/Kg. However, PQ interval of electrocardiogram became shorter. Intravenous administrations of SG 75 in doses of 50 and 150 microgram/Kg caused an increase in blood flow of the constricted coronary artery, while nitroglycerin (10 and 30 microgram/Kg) and nifedipine (1 and 3 microgram/Kg) reduced it. The results indicate that SG 75 is a potent and long-acting coronary vasodilating agent and it causes an increase in blood flow of constricted as well as non-constricted coronary artery.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 148520     DOI: 10.1536/ihj.19.112

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  24 in total

1.  Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs.

Authors:  P D Verdouw; L M Sassen; D J Duncker; I O Schmeets; R J Rensen; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

2.  Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.

Authors:  T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

Review 3.  Effects of nicorandil on regional perfusion and left ventricular function.

Authors:  M Schlepper; J Thormann; K Berwing; R Strasser; V Mitrovic
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

4.  Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility.

Authors:  A Baumbach; U Braun; G Döring; K K Haase; W Voelker; K R Karsch
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 5.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

6.  Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.

Authors:  J Yamazaki; H Ohsawa; T Uchi; M Iida; H Nakano; H Hosoi; T Morishita; Y Yabe; N Koyama; H Komatsu
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.

Authors:  S Di Somma; V Liguori; M Petitto; A Carotenuto; D Bokor; O de Divitiis; M de Divitiis
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

8.  Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.

Authors:  A Miwa; S Kaneta; K Motoki; Y Jinno; H Kasai; Y Okada; H Fukushima; N Ogawa
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs.

Authors:  Y Abiko; T Nishimura; K Sakai
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

10.  Pharmacokinetics of nicorandil in patients with normal and impaired renal function.

Authors:  M Molinaro; G Villa; M B Regazzi; A Salvadeo; S Segagni; R Rondanelli; E Sartirana
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.